The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults
Abstract
CONTEXT: High chronic exposure to inorganic arsenic in drinking water has been related to diabetes development, but the effect of exposure to low to moderate levels of inorganic arsenic on diabetes risk is unknown. In contrast, arsenobetaine, an organic arsenic compound derived from seafood intake, is considered nontoxic. OBJECTIVE: To investigate the association of arsenic exposure, as measured in urine, with the prevalence of type 2 diabetes in a representative sample of US adults. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study in 788 adults aged 20 years or older who participated in the 2003-2004 National Health and Nutrition Examination Survey (NHANES) and had urine arsenic determinations. MAIN OUTCOME MEASURE: Prevalence of type 2 diabetes across intake of arsenic. RESULTS: The median urine levels of total arsenic, dimethylarsinate, and arsenobetaine were 7.1, 3.0, and 0.9 mug/L, respectively. The prevalence of type 2 diabetes was 7.7%. After adjustment for diabetes risk factors and markers of seafood intake, participants with type 2 diabetes had a 26% higher level of total arsenic (95% confidence interval [CI], 2.0%-56.0%) and a nonsignificant 10% higher level of dimethylarsinate (95% CI, -8.0% to 33.0%) than participants without type 2 diabetes, and levels of arsenobetaine were similar to those of participants without type 2 diabetes. After similar adjustment, the odds ratios for type 2 diabetes comparing participants at the 80th vs the 20th percentiles were 3.58 for the level of total arsenic (95% CI, 1.18-10.83), 1.57 for dimethylarsinate (95% CI, 0.89-2.76), and 0.69 for arsenobetaine (95% CI, 0.33-1.48). CONCLUSIONS: After adjustment for biomarkers of seafood intake, total urine arsenic was associated with increased prevalence of type 2 diabetes. This finding supports the hypothesis that low levels of exposure to inorganic arsenic in drinking water, a widespread exposure worldwide, may play a role in diabetes prevalence. Prospective studies in populations exposed to a range of inorganic arsenic levels are needed to establish whether this association is causal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
A review of the source, behaviour and distribution of arsenic in natural waters
Smedley, P. L., & Kinniburgh, D. G. (2002) · Applied Geochemistry · doi:10.1016/s0883-2927(02)00018-5 · Cited by 7,691
Arsenic speciation in the environment
Cullen, W. R., & Reimer, K. J. (1989) · Chemical Reviews · doi:10.1021/cr00094a002 · Cited by 2,587
Petrusevski, B., Sharma, S. K., Shordt, K., Schippers, J. C., & van Wijk, C. (2009) · Cited by 1,273
The Cellular Metabolism and Systemic Toxicity of Arsenic
Thomas, D. J., Styblo, M., & Lin, S. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9258 · Cited by 592
A Market Basket Survey of Inorganic Arsenic in Food
Schoof, R. A., Yost, L. J., Eickhoff, J., Crecelius, E. A., Cragin, D. W., Meacher, D. M., & Menzel, D. B. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00073-3 · Cited by 487
Arsenic Exposure and Cardiovascular Disease: A Systematic Review of the Epidemiologic Evidence
Navas-Acien, A., Sharrett, A. R., Silbergeld, E. K., Schwartz, B. S., Nachman, K. E., Burke, T. A., & Guallar, E. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi330 · Cited by 412
Self-citationDrinking water arsenic in Utah: A cohort mortality study.
Lewis, D. R., Southwick, J. W., Ouellet-Hellstrom, R., Rench, J., & Calderon, R. L. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107359 · Cited by 372
Francesconi, K. A., & Edmonds, J. S. (1996) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60130-0 · Cited by 365
Ingested Inorganic Arsenic and Prevalence of Diabetes Mellitus
Lai, M.-S., Hsueh, Y.-M., Chen, C.-J., Shyu, M.-P., Chen, S.-Y., Kuo, T.-L., Wu, M.-M., & Tai, T.-Y. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117031 · Cited by 354
Cited by
Arsenic Exposure and Toxicology: A Historical Perspective
Hughes, M. F., Beck, B. D., Chen, Y., Lewis, A. S., & Thomas, D. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr184 · Cited by 1,312
Shared decision making: really putting patients at the centre of healthcare
Stiggelbout, A. M., Weijden, T. V. D., Wit, M. P. T. D., Frosch, D., Legare, F., Montori, V. M., Trevena, L., & Elwyn, G. (2012) · BMJ · doi:10.1136/bmj.e256 · Cited by 1,014
Arsenic and human health effects: A review
Mohammed Abdul, K. S., Jayasinghe, S. S., Chandana, E. P. S., Jayasumana, C., & De Silva, P. M. C. S. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.09.016 · Cited by 907
Limón-Pacheco, J., & Gonsebatt, M. E. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.09.015 · Cited by 844
Arsenic-induced oxidative stress and its reversibility
Flora, S. J. S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.008 · Cited by 824
Metadata
- Authors
- Navas-Acien, A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-08-20
- Volume
- 300
- Issue
- 7
- Pages
- 814
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1967908741
- Cited by
- 467
- References
- 41
- FWCI
- 20.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults. https://app.cochat.ai/papers/10.1001/jama.300.7.814
- The paper
- Navas-Acien, A. (2008). Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults. JAMA. https://doi.org/10.1001/jama.300.7.814
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.